SCHEMBL6185503

SCHEMBL6185503

Cc1nc2ccc(OC3CN(CC(C)O)CCN3)cc2s1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
KMT2A Q03164 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
ALOX15 P16050 1/20 0.35
HPGD P15428 2/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6186053 0.92 CYP3A4 (0.41) CYP3A4
SCHEMBL5745430 0.92 CYP3A4 (0.41) CYP3A4
SCHEMBL6185748 0.81 NPC1 (0.34) KMT2ANPC1RAB9ACYP3A4
SCHEMBL6185575 0.79 NPC1 (0.40) L3MBTL1KMT2ASMN1; SMN2MEN1NPC1
SCHEMBL8349073 0.79 USP2 (0.41) KMT2AMEN1MAPTTSHR
SCHEMBL6184734 0.76 GRIN1 (0.40) L3MBTL1KMT2ASMN1; SMN2MEN1MAPT
SCHEMBL6188783 0.75 TLR9 (0.47)
SCHEMBL6185585 0.75 TP53 (0.41) L3MBTL1MAPTKDM4E
SCHEMBL6186925 0.73 ACSL1 (0.47) KMT2ASMN1; SMN2MEN1NPC1RAB9A
SCHEMBL6188276 0.72 NPC1 (0.43) KMT2ASMN1; SMN2MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567525-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2005-08-31 EP disclosed
WO-2004052887-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-06-24 WO disclosed